NeuroPace (NPCE) Return on Equity (2020 - 2025)
Historic Return on Equity for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to 1.23%.
- NeuroPace's Return on Equity rose 16800.0% to 1.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.23%, marking a year-over-year increase of 16800.0%. This contributed to the annual value of 1.91% for FY2024, which is 7400.0% down from last year.
- Latest data reveals that NeuroPace reported Return on Equity of 1.23% as of Q3 2025, which was up 16800.0% from 1.17% recorded in Q2 2025.
- In the past 5 years, NeuroPace's Return on Equity ranged from a high of 0.62% in Q2 2021 and a low of 3.08% during Q4 2024
- Moreover, its 5-year median value for Return on Equity was 1.23% (2025), whereas its average is 1.29%.
- In the last 5 years, NeuroPace's Return on Equity tumbled by -13500bps in 2022 and then skyrocketed by 16800bps in 2025.
- NeuroPace's Return on Equity (Quarter) stood at 0.4% in 2021, then crashed by -202bps to 1.2% in 2022, then crashed by -47bps to 1.76% in 2023, then tumbled by -75bps to 3.08% in 2024, then surged by 60bps to 1.23% in 2025.
- Its last three reported values are 1.23% in Q3 2025, 1.17% for Q2 2025, and 1.55% during Q1 2025.